Literature DB >> 24871133

CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus.

Xiaoming Zhang1, Brian Mozeleski2, Sebastien Lemoine2, Edith Dériaud2, Annick Lim3, Dania Zhivaki2, Elie Azria4, Camille Le Ray5, Gwenaelle Roguet6, Odile Launay7, Anne Vanet8, Claude Leclerc2, Richard Lo-Man9.   

Abstract

The T cell compartment is considered to be naïve and dedicated to the development of tolerance during fetal development. We have identified and characterized a population of fetally developed CD4 T cells with an effector memory phenotype (TEM), which are present in cord blood. This population is polyclonal and has phenotypic features similar to those of conventional adult memory T cells, such as CD45RO expression. These cells express low levels of CD25 but are distinct from regulatory T cells because they lack Foxp3 expression. After T cell receptor activation, neonatal TEM cells readily produced tumor necrosis factor-α (TNF-α) and granulocyte-macrophage colony-stimulating factor (GM-CSF). We also detected interferon-γ (IFN-γ)-producing T helper 1 (TH1) cells and interleukin-4 (IL-4)/IL-13-producing TH2-like cells, but not IL-17-producing cells. We used chemokine receptor expression patterns to divide this TEM population into different subsets and identified distinct transcriptional programs using whole-genome microarray analysis. IFN-γ was found in CXCR3(+) TEM cells, whereas IL-4 was found in both CXCR3(+) TEM cells and CCR4(+) TEM cells. CCR6(+) TEM cells displayed a genetic signature that corresponded to TH17 cells but failed to produce IL-17A. However, the TH17 function of TEM cells was observed in the presence of IL-1β and IL-23. In summary, in the absence of reported pathology or any major infectious history, T cells with a memory-like phenotype develop in an environment thought to be sterile during fetal development and display a large variety of inflammatory effector functions associated with CD4 TH cells at birth.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2014        PMID: 24871133     DOI: 10.1126/scitranslmed.3008748

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  60 in total

Review 1.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

2.  The sterile and tolerogenic fetal niche does not restrict the generation of CD4 T memory cells.

Authors:  Alexandre Morrot
Journal:  Ann Transl Med       Date:  2015-04

3.  T cell activation in utero: self or non-self discrimination.

Authors:  Adriana Bonomo; Wilson Savino
Journal:  Ann Transl Med       Date:  2015-04

Review 4.  Unique aspects of the perinatal immune system.

Authors:  Xiaoming Zhang; Dania Zhivaki; Richard Lo-Man
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

Review 5.  Chorioamnionitis, IL-17A, and fetal origins of neurologic disease.

Authors:  Shelley M Lawrence; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-22       Impact factor: 3.886

Review 6.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

7.  Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood.

Authors:  Laura F Su; Daniel Del Alcazar; Erietta Stelekati; E John Wherry; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

Review 8.  Impact of pregravid obesity on maternal and fetal immunity: Fertile grounds for reprogramming.

Authors:  Suhas Sureshchandra; Nicole E Marshall; Ilhem Messaoudi
Journal:  J Leukoc Biol       Date:  2019-09-04       Impact factor: 4.962

9.  In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes.

Authors:  Poojitha Matta; Stacy D Sherrod; Christina C Marasco; Daniel J Moore; John A McLean; Joern-Hendrik Weitkamp
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

Review 10.  Very early combination antiretroviral therapy in infants: prospects for cure.

Authors:  Kaitlin Rainwater-Lovett; Katherine Luzuriaga; Deborah Persaud
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.